Scientific Letter
Susceptibility to azithromycin in non-typhoid Salmonella: A therapeutic option
Sensibilidad a azitromicina en Salmonella no tifoidea: opción terapéutica
María José González-Abad
, Mercedes Alonso Sanz
Corresponding author
Sección de Microbiología, Servicio de Análisis Clínicos, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
Read
3827
Timeswas read the article
1521
Total PDF
2306
Total HTML
Share statistics
array:24 [ "pii" => "S2341287921001800" "issn" => "23412879" "doi" => "10.1016/j.anpede.2020.11.008" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "3021" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2021;95:468-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1695403320304847" "issn" => "16954033" "doi" => "10.1016/j.anpedi.2020.11.003" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "3021" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2021;95:468-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICA</span>" "titulo" => "Sensibilidad a azitromicina en <span class="elsevierStyleItalic">Salmonella</span> no tifoidea: opción terapéutica" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "468" "paginaFinal" => "469" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Susceptibility to azithromycin in non-typhoid <span class="elsevierStyleItalic">Salmonella:</span> A therapeutic option" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María José González-Abad, Mercedes Alonso Sanz" "autores" => array:2 [ 0 => array:2 [ "nombre" => "María José" "apellidos" => "González-Abad" ] 1 => array:2 [ "nombre" => "Mercedes" "apellidos" => "Alonso Sanz" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2341287921001800" "doi" => "10.1016/j.anpede.2020.11.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287921001800?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403320304847?idApp=UINPBA00005H" "url" => "/16954033/0000009500000006/v2_202112240557/S1695403320304847/v2_202112240557/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S234128792100171X" "issn" => "23412879" "doi" => "10.1016/j.anpede.2020.10.009" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "3003" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2021;95:470-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Seronegative immune-mediated necrotising myopathy with myocardial involvement" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "470" "paginaFinal" => "472" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Miopatía necrosante inmunomediada seronegativa con afectación miocárdica" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 820 "Ancho" => 1760 "Tamanyo" => 166911 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">a) Facial hypopigmentation (periocular and perioral); b) Skill with an atrophic, shiny and hyperpigmented appearance at the sternal level; c) Hyperpigmentation and psoriasiform desquamative lesions on knees; d) Coronal view on MRI (extensive involvement of muscles of both shoulders, thorax and proximal arm, bilateral and symmetric, hyperintense signal in STIR sequence indicative of oedema); e) Digital ulcers; f) Scleroderma in hands, difficulty making a fist (frontal view); g) Scleroderma in hands, difficulty making a fist (lateral view).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Laura Martín Pedraz, Rocío Galindo Zavala, Cristina Yun Castilla, Almudena Ortiz Garrido, Esmeralda Núñez Cuadros" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Laura" "apellidos" => "Martín Pedraz" ] 1 => array:2 [ "nombre" => "Rocío" "apellidos" => "Galindo Zavala" ] 2 => array:2 [ "nombre" => "Cristina" "apellidos" => "Yun Castilla" ] 3 => array:2 [ "nombre" => "Almudena" "apellidos" => "Ortiz Garrido" ] 4 => array:2 [ "nombre" => "Esmeralda" "apellidos" => "Núñez Cuadros" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403320304501" "doi" => "10.1016/j.anpedi.2020.10.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403320304501?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S234128792100171X?idApp=UINPBA00005H" "url" => "/23412879/0000009500000006/v2_202112161235/S234128792100171X/v2_202112161235/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2341287921001812" "issn" => "23412879" "doi" => "10.1016/j.anpede.2020.11.009" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "3030" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2021;95:467-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Acute pyomyositis: Diagnosis and treatment of 3 cases in a secondary hospital" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "467" "paginaFinal" => "468" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Piomiositis aguda: diagnóstico y tratamiento de 3 casos en un hospital de segundo nivel" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Leyre López Fernández, Verónica Jiménez Escobar, Isabel Sáenz Moreno, Eduardo Gallinas Maraña, Laura Cuadrado Piqueras" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Leyre" "apellidos" => "López Fernández" ] 1 => array:2 [ "nombre" => "Verónica" "apellidos" => "Jiménez Escobar" ] 2 => array:2 [ "nombre" => "Isabel" "apellidos" => "Sáenz Moreno" ] 3 => array:2 [ "nombre" => "Eduardo" "apellidos" => "Gallinas Maraña" ] 4 => array:2 [ "nombre" => "Laura" "apellidos" => "Cuadrado Piqueras" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403320304938" "doi" => "10.1016/j.anpedi.2020.11.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403320304938?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287921001812?idApp=UINPBA00005H" "url" => "/23412879/0000009500000006/v2_202112161235/S2341287921001812/v2_202112161235/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Susceptibility to azithromycin in non-typhoid <span class="elsevierStyleItalic">Salmonella</span>: A therapeutic option" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "468" "paginaFinal" => "469" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "María José González-Abad, Mercedes Alonso Sanz" "autores" => array:2 [ 0 => array:4 [ "nombre" => "María José" "apellidos" => "González-Abad" "email" => array:1 [ 0 => "mglezabad@yahoo.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Mercedes" "apellidos" => "Alonso Sanz" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Sección de Microbiología, Servicio de Análisis Clínicos, Hospital Infantil Universitario Niño Jesús, Madrid, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Sensibilidad a azitromicina en <span class="elsevierStyleItalic">Salmonella</span> no tifoidea: opción terapéutica" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">As the prevalence of antimicrobial resistance continues to increase, epidemiological surveillance of in vitro susceptibility is crucial. For the purpose of monitoring these data on an ongoing basis, clinical or epidemiological cut-off points are indispensable tools that have to be made available. On the other hand, although uncomplicated infections by nontyphoidal <span class="elsevierStyleItalic">Salmonella enterica</span> (NTS) do not usually require antibiotherapy, certain patients with immunodeficiencies or of extreme age, among other possible circumstances, may benefit from administration of broad-spectrum cephalosporins or fluoroquinolones to reduce the risk of bacteraemia and extraintestinal infection. However, their excessive use for treatment of animal and human infections has led to an increase in the isolation of resistant strains. In this context, azithromycin emerges as a possible alternative.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> However, none of the committees on antimicrobial susceptibility (Clinical and Laboratory Standards Institute [CLSI] and European Committee on Antimicrobial Susceptibility Testing [EUCAST]) have defined azithromycin clinical cut-off points for treatment of NTS to date.</p><p id="par0010" class="elsevierStylePara elsevierViewall">As surveillance programmes become aware of the importance of detecting drug resistance mechanisms, epidemiological cut-off points may be useful when clinical cut-off points are not available. Thus, many studies have applied the epidemiological cut-off values (ECOFF) defined by the EUCAST for azithromycin and <span class="elsevierStyleItalic">Salmonella enterica</span> serotype Typhimurium to interpret in vitro susceptibility data, especially in endemic areas.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> When it comes to NTS, the lack of epidemiological cut-off points for azithromycin combined with the recommendation against the routine use of antibiotherapy in infections by these serotypes have resulted in a dearth of studies on their in vitro susceptibility. Published studies have usually applied the ECOFF established for the susceptibility of <span class="elsevierStyleItalic">Salmonella enterica</span> serotype Typhi (<span class="elsevierStyleItalic">Salmonella</span> Typhi) to azithromycin.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4–6</span></a> Our aim was to provide information on the in vitro susceptibility to azithromycin of the NTS strains causing acute gastroenteritis in the patients managed in our hospital to contribute to the knowledge on the usefulness of this drug as an alternative treatment option in patients with salmonellosis.</p><p id="par0015" class="elsevierStylePara elsevierViewall">At the Hospital Infantil Universitario Niño Jesús (Madrid, Spain), antimicrobial susceptibility testing was performed in 124 NTS strains (1 strain per patient) out of a total of 212 strains isolated between 2016 and 2019. Susceptibility testing was performed by the diffusion gradient method (Etest MIC Evaluator™, Oxoid, bioMérieux) applying the ECOFF for <span class="elsevierStyleItalic">Salmonella</span> Typhi established by EUCAST (minimum inhibitory concentration [MIC] ≤ 16 mg/L). The zone of inhibition was measured over a black background using reflected light and a magnifying glass. In 98% of strains, the MIC of azithromycin was 16 mg/L or less. The MICs of azithromycin in the 121 strains ranged from 0.75 to 16 mg/L (median, 3 mg/L). The MIC of azithromycin in 3 strains exceeded the ECOFF. Of all strains, 41% were resistant to amoxicillin, 6% to trimethoprim-sulfamethoxazole and 2% to ciprofloxacin. Seven isolates had resistance to both amoxicillin and trimethoprim-sulfamethoxazole. None of the isolates was resistant to cefotaxime. The <span class="elsevierStyleItalic">Salmonella</span> infection was acquired in the community in 194 patients (92%), of who 13% required hospital admission due to protracted or severe diarrhoea, comorbidities or the development of bacteraemia. Twenty-six percent of patients belonged to risk groups and therefore candidates for antibiotherapy. Nine (4%) had some form of cancer and 41 (19%), who were not oncology patients, were aged up to 12 months at the onset of the episode of gastroenteritis (23% of these patients were aged up to 3 months). We ought to highlight 6 patients (3%) treated with third-generation cephalosporins. Three of them developed bacteraemia by NTS, 1 had Crohn disease and the remaining 2 had a clinical diagnosis without microbiological confirmation and received treatment for suspected food poisoning with NTS, which was confirmed later by isolation in stool culture. Interestingly, the review of the health records revealed 1 case in which azithromycin was administered after isolation of both NTS and <span class="elsevierStyleItalic">Campylobacte</span>r species in the stool culture, with successful resolution of disease. Thus, a single antibiotic agent may be effective against 2 of the most frequent pathogens that cause bacterial gastroenteritis in our region.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Our findings add to the data published to date that, based on in vitro susceptibility results, it supports the use of azithromycin as alternative treatment of NTS infection in cases without sepsis or to complete treatment if bacteraemia is suspected. Several studies in Europe have reported MICs of azithromycin of 4–8 mg/L for a majority of the tested NTS isolates.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,5</span></a> In one of the few studies conducted in Spain, Martín-Pozo et al<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> found a MICs ranging from 6 to 48 mg/L in 64 NTS isolates, with a single resistant strain (MIC = 48 mg/L). Azithromycin also has an intermediate half-life, excellent tissue penetration and the advantage that it can be administered orally. All of it makes its use attractive, particularly in paediatric clinical practice, in which quinolones must be used with caution, under specific circumstances or as second-line treatment, and in which shorter courses of treatment would facilitate adherence. Nevertheless, studies need to be conducted to establish its efficacy and define clinical and/or epidemiological cut-off points to help select the best possible treatment.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: González-Abad MJ, Alonso Sanz M. Sensibilidad a azitromicina en <span class="elsevierStyleItalic">Salmonella</span> no tifoidea: opción terapéutica. An Pediatr (Barc). 2021;95:468–469.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Enteric fever in a UK regional infectious diseases unit: a 10 year retrospective review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "T.W. Clark" 1 => "C. Daneshvar" 2 => "M. Pareek" 3 => "N. Perera" 4 => "I. Stephenson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jinf.2009.11.009" "Revista" => array:6 [ "tituloSerie" => "J Infect." "fecha" => "2010" "volumen" => "60" "paginaInicial" => "91" "paginaFinal" => "98" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19962402" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "E.E. Effa" 1 => "H. Bukirwa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD006083.pub2" "Revista" => array:2 [ "tituloSerie" => "Cochrane Database Syst Rev." "fecha" => "2008" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinically and microbiologically derived azithromycin susceptibility breakpoints for <span class="elsevierStyleItalic">Salmonella enterica</span> serovars Typhi and Paratyphi A" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.M. Parry" 1 => "N.T.V. Thieu" 2 => "C. Dolecek" 3 => "A. Karkey" 4 => "R. Gupta" 5 => "P. Turner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/AAC.04729-14" "Revista" => array:6 [ "tituloSerie" => "Antimicrob Agents Chemother." "fecha" => "2015" "volumen" => "59" "paginaInicial" => "2756" "paginaFinal" => "2764" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25733500" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "<span class="elsevierStyleItalic">In vitro</span> activity of azithromycin against nontyphoidal <span class="elsevierStyleItalic">Salmonella enterica</span>" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Gunell" 1 => "P. Kotilainen" 2 => "J. Jalava" 3 => "P. Huovinen" 4 => "A. Siitonen" 5 => "A.J. Hakanen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/AAC.01678-09" "Revista" => array:6 [ "tituloSerie" => "Antimicrob Agents Chemother." "fecha" => "2010" "volumen" => "54" "paginaInicial" => "3498" "paginaFinal" => "3501" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20498312" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Resistance to ampicillin, third-generation cephalosporins, ciprofloxacin, co-trimoxazole and azithromycin in clinical isolates of Salmonella enterica subsp. enterica from Germany: Real problem or sporadic circumstance?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Müller" 1 => "D. Tappe" 2 => "M. Frosch" 3 => "M. Abele-Horn" 4 => "G. Valenza" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Scand J Infect Dis." "fecha" => "2011" "volumen" => "43" "paginaInicial" => "389" "paginaFinal" => "391" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sensibilidad a azitromicina y otros antibióticos en aislados recientes de <span class="elsevierStyleItalic">Salmonella</span>, <span class="elsevierStyleItalic">Shigella</span> y <span class="elsevierStyleItalic">Yersinia</span>" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Martín-Pozo" 1 => "D.M. Arana" 2 => "M. Fuentes" 3 => "J.I. Alós" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.eimc.2014.02.010" "Revista" => array:6 [ "tituloSerie" => "Enferm Infecc Microbiol Clin." "fecha" => "2014" "volumen" => "32" "paginaInicial" => "369" "paginaFinal" => "371" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24698008" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23412879/0000009500000006/v2_202112161235/S2341287921001800/v2_202112161235/en/main.assets" "Apartado" => array:4 [ "identificador" => "38181" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23412879/0000009500000006/v2_202112161235/S2341287921001800/v2_202112161235/en/main.pdf?idApp=UINPBA00005H&text.app=https://analesdepediatria.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287921001800?idApp=UINPBA00005H" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 10 | 10 | 20 |
| 2024 October | 61 | 39 | 100 |
| 2024 September | 68 | 37 | 105 |
| 2024 August | 89 | 69 | 158 |
| 2024 July | 82 | 38 | 120 |
| 2024 June | 88 | 44 | 132 |
| 2024 May | 69 | 48 | 117 |
| 2024 April | 75 | 39 | 114 |
| 2024 March | 58 | 35 | 93 |
| 2024 February | 74 | 49 | 123 |
| 2024 January | 61 | 40 | 101 |
| 2023 December | 105 | 49 | 154 |
| 2023 November | 64 | 61 | 125 |
| 2023 October | 77 | 37 | 114 |
| 2023 September | 40 | 39 | 79 |
| 2023 August | 36 | 25 | 61 |
| 2023 July | 58 | 46 | 104 |
| 2023 June | 46 | 30 | 76 |
| 2023 May | 41 | 34 | 75 |
| 2023 April | 22 | 20 | 42 |
| 2023 March | 45 | 33 | 78 |
| 2023 February | 46 | 23 | 69 |
| 2023 January | 37 | 42 | 79 |
| 2022 December | 75 | 34 | 109 |
| 2022 November | 62 | 49 | 111 |
| 2022 October | 67 | 60 | 127 |
| 2022 September | 61 | 24 | 85 |
| 2022 August | 70 | 47 | 117 |
| 2022 July | 48 | 41 | 89 |
| 2022 June | 58 | 38 | 96 |
| 2022 May | 57 | 39 | 96 |
| 2022 April | 81 | 37 | 118 |
| 2022 March | 87 | 58 | 145 |
| 2022 February | 60 | 32 | 92 |
| 2022 January | 68 | 77 | 145 |
| 2021 December | 105 | 61 | 166 |
| 2021 November | 55 | 37 | 92 |
Show all
